Antigen test kit - Import export

The FlowFlex Rapid Lateral Flow Antigen Test Kit uses the latest patented technology to detect proteins, ensuring that it can detect new strains of the COVID-19 virus. Using a simple nasal swab within 2cm of the nose makes it extremely easy to administer an accurate test.

The Flowflex™ COVID19 Antigen Home Test is all you need to determine your family’s Covid19 status, whether symptoms are present or not. Can be used on children as young as 2 years old. Get the convenience of Flowflex! Easy and Affordable Highly Accurate Nasal Swab Test Quick Results in 15 minutes Safe for children as young as 2 years old For use with and without symptoms

Notable features of Malaria Rapid Test Reliable and inexpensive Convenient and easytounderstand directions Clear preparation procedures Simple and safe specimen collection directions Comprehensive package of required materials and components Rapid and accurate test results Diagnostic Automation Inc. also offers other Infectious Diseases Rapid tests, and Infectious Diseases ELISA test kits. For more information about Rapid tests, CLIA tests, IFA kits, or ELISA test kits. Malaria Rapid Test Principle A rapid test for the qualitative detection of Malaria pf and pv antigen in human blood sample. The Malaria pf (HRP II) / pv (LDH) Antigen Test contains a membrane strip, which is precoated with two monoclonal antibodies as two separate lines across a test strip. One monoclonal antibody(test line 1) is specific to the P. falciparum histidine rich protein2 (PfHRP2) and another monoclonal antibody (test line 2) is specific to the lactate

CPV is a highly contagious viral disease of dogs that commonly causes acute gastrointestinal illness in puppies. The disease most often strikes in pups between six and 20 weeks old, but older animals are sometimes also affected. A rare variant of the disease that may be seen in very young (neonatal) puppies is myocarditis (an inflammation of the heart muscle).. Key facts of the Canine Parvovirus Antigen Test Card Ready to use kits for pet owners and vet clinic No special instrument required Suitable for field test Result in 10min. What are the treatment options for dogs with CPV? Treatment options for dogs suffering from CPV involve supportive care and management of symptoms. Treatment options will vary, depending on how sick the dog is, but certain aspects are considered vital for all patients. A hospital stay is often necessary so that the dog can receive intravenous fluids and nutrients to replace the vast quantities lost via vomiting and diarrhea. An intravenous drip

This SARS-CoV-2 & Flu A+B Antigen Combo Rapid Test Kit is only used for rapid in vitroqualitative detection of SARS-CoV-2, influenza A and influenza B nucleoprotcin antigens innasopharyngeal swab, nasal swab, oropharyngeal swab or saliva specimens. It is intended toaid in the rapid differential diagnosis of SARS-CoV-2, influenza A and influenza B viral infections. Negative test results do not preclude SARS-CoV-2 or influenza infections andshould not be used as the sole basis for treatment or other patient management decisions.

The SARSCoV2 Antigen Rapid Test Kit is a colloidal gold enhanced double antibody san dwich immunoassay for the qualitative determination of SARSCoV2 antigen.The test region (T) of nitrocellulose membrane was immobilized with mouse anti SARSCoV2 antibody 1 (Ab1), and the control region (C) was immobilized with Goat anti chicken IgY antibody (GAC). At the same time, the binding pad of the test card was fixed with mouse anti SARSCoV2 antibody 2 (Ab2) a nd chicken IgY (CIgY) which were both labeled by colloidal gold.

The Covid-19 Antigen Rapid Test Casserre is a lateral flow immunoassay intended fort he qualitative detection Sars-Cov-2 nucleocapsid antigens in nasophartngeal swab and orosharyngeal wsab from individuals wha are suspected of COVID-19 by their healtcare provider.

Antigen Diagnostic Kit Rapid test kit results in 20 minutes Used at the point of care by medical professionals

Covid-19 Antigen Rapid test for proffessional use

Boson Biotech-Rapid SARS-CoV-2 Antigen test card Corona virus SELF anterior nasal swab Covid rapid antigen test. The Rapid SARS-CoV-2 Antigen test card from Boson Biotech is a covid self-diagnostic test. Registered at the Ministry of Health Min. Sal. n° 2089498 CE Mark 0123, Certificate No.: V90613170006 Rev.00 of 01/04/2021 Diagnostic sensitivity: 96.77% - Diagnostic specificity: 99.20%. DE + AT approved "Laientest" BfArM approved "Laientest" in Germany (special approval 5640-S-007/21) Austria: For home and self-applying according to §323c ABS 18 BAO approved BAG-listed High Accuracy: nasopharyngeal swab collection with clinically proven high accuracy results. Usability: any adult can easily use our three-step, cost-effective portable testing kit. Easy to Use: Testing can be easily administered in almost any environment without additional special equipment. Easy to transport with no special storage requirements, a test kit is all you need.

GENRUI® COVID-19 Rapid Antigen Test for Home, Applications, nasal Sampling, CE certified The Rapid SARS-CoV-2 Antigen test card from Genrui is a Covid-19 self-diagnostic test. The COVID-19 Antigen Rapid Test is a lateral flow immunoassay based on the principle of double antibody sandwich technology. The SARS-CoV-2 nucleocapsid protein monoclonal antibody conjugated with colored microparticles is used as a detector and sprayed onto the conjugation pad. During the test, the SARS-CoV-2 antigen in the sample interacts with the SARS-CoV-2 antibody, which is conjugated with colored microparticles, creating an antigen-antibody-labeled complex. This complex migrates via capillary action on the membrane to the test line, where it is captured by the pre-coated monoclonal SARS-CoV-2 nucleocapsid protein antibody. A colored test line (T) would be visible in the result window if SARS-CoV-2 antigens are present in the sample. The absence of the T-line indicates a negative result.

The TÜV-certified CLUNGSE COVID-19 antigen test is a rapid test for the qualitative detection of nucleocapsid protein antigens in nasal or nasopharyngeal swabs. The SARS-CoV-2 test listed by the BfArM may be carried out either by medical professionals or by appropriately trained professionals. The 3in1 antigen test is characterized by new batches that recognize Omikron with high specificity and are optimized for professional use. The tests are prefilled, the buffer solution bottle is sealed for error-free handling and the sample can be taken via the following swabs: nasal, oropharyngeal and nasopharyngeal. Thanks to the high sensitivity and specificity, the test result is particularly reliable. The test can already be read after 10 - 15 minutes. • 3in1 antigen test according to the Federal Institute for Drugs and Medical Devices approval AT079/20 • Format - Immunoassay​ • Sampling Nasopharyngeal swab and/or nasal • Packaging 25 tests per case

BfArM listed: AT563/21 Evaluated by the Paul Ehrlich Institute Reliable with 96% sensitivity and 99% specificity Use only by medically trained personnel

Rapid antigen test COVID-19 swab test LIFECOSM - 25 pieces - SARS-CoV-2 to the extended 4in1 successor article most sensitive rapid corona test in Germany according to the Paul Ehrlich Institute (PEI) listed at the BfArM 100% overall sensitivity according to PEI -> AT1054/21 | AT 1055/21 | AT1056/21 | AT1340/21 | AT1361/21 -> same test cassette detects current virus mutations, reliable at Omikron reimbursable by test regulation

COVID-19 Antigen Detection Kit - Nasal Swab The Rapid SARS-CoV-2 Antigen test card from New Gene is a Covid-19 self-diagnostic test. New Gene (Hangzhou) Bioengineering Co., Ltd. is located in Hangzhou, China. It is a high-tech company engaged in the research, development, manufacture and distribution of biological products. It is committed to creating biological materials such as antigens and antibodies, in vitro diagnostic reagents and related devices, and also the complete industrial chain of artificial intelligence assisted diagnosis system. The product line covers a full range of in vitro diagnostic products such as immune diagnosis, molecular diagnosis, and microbiological testing. NEWGENE has profound technical accumulation and unique technological advantages in the areas of early cancer screening, rapid detection of infectious diseases, and rapid screening of geriatric diseases. NEWGENE's manufacturing system meets GMP standards for medical devices, and is certified with ISO1

With the self/rapid test you get a high-quality corona antigen self-test, which is used for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in the front nasal cavity in a short time. It is based on the lateral flow immunoassay method, which uses antibodies to detect specific antigens in the sample swab.

Easy handling thanks to minimally invasive sampling as a nasal swab (2.5 cm depth) Also very good for use with small children, students, handicapped people, professional sports activities and in companies This test is Made in Germany and approved for use by laypersons Reliable with 100% sensitivity and 98% specificity

Hotgen COVID-19 Rapid Antigen Test for Home, Applications, nasal Sampling, CE certified The Rapid SARS-CoV-2 Antigen test card from Hotgen is a Covid-19 self-diagnostic test. The set is used for the qualitative in vitro determination of SARS-CoV-2 antigen in human anterior nasal samples. It serves as a rapid examination in suspected cases of novel coronavirus, but can also be used as a confirmation method for the detection of nucleic acids in discharged cases. Fast and reliable test results within 15 minutes Simple nasal swab test for laypeople Store at room temperature Can be used anywhere Shelf life up to 18 months Test can be performed quickly and easily without special equipment File number of the special approval of the BfArM 5640 S 057/21 Certified CE 0123

The Sentebiolab Senteligo™️ SARS-CoV-2 (COVID-19) Multiplex qPCR Detection test includes a Primer-Probe set inside the Reaction Mix that contains primers and probes for human RNaseP and viral N1 and N2 regions. The internal control (primer/probe set for human RNaseP gene) is used to identify possible qPCR inhibition, confirm the integrity of the reagents, and verify the quality of RNA extraction from patient material. RNaseP primers and probes included in the kit recognize the human RNaseP gene. The primers and probes for viral N1 and N2 regions specifically identify two distinct regions on the nucleocapsid (N) gene of the SARS-CoV-2 virus. These primers and probes do not recognize the SARS-CoV virus, whose genetic structure is highly similar to SARS-CoV-2.